Yehuda Chowers

Haifa, HA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

The Israeli IBD Research Nucleus: collaborative advancements in Israeli IBD research.

The Israeli IBD Research Nucleus: collaborative advancements in Israeli IBD research.

Journal: Therapeutic advances in gastroenterology

Published: January 17, 2026

Drug-Tolerant, Chemiluminescent Lateral Flow Immunoassay Platform for the Determination of Neutralizing Anti-Drug Antibodies.

Drug-Tolerant, Chemiluminescent Lateral Flow Immunoassay Platform for the Determination of Neutralizing Anti-Drug Antibodies.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 19, 2025

Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource.

Characteristics and Outcomes of Over a Million Patients with Inflammatory Bowel Disease in Seven Countries: Multinational Cohort Study and Open Data Resource.

Journal: Digestive diseases and sciences

Published: September 10, 2024

Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.

Durability of the First Biologic in Children and Adults With Ulcerative Colitis: A Nationwide Study from the epi-IIRN.

Journal: Inflammatory bowel diseases

Published: October 27, 2023

Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.

Durability of the First Biologic in Patients with Crohn's Disease: A Nationwide Study from the epi-IIRN.

Journal: Journal of Crohn's & colitis

Published: July 19, 2023

Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN.

Association of Antibiotic Use with Durability of Biologic Agents in Inflammatory Bowel Disease: a Report from the epi-IIRN.

Journal: Journal of Crohn's & colitis

Published: April 21, 2023

Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota.

Inflammation and bacteriophages affect DNA inversion states and functionality of the gut microbiota.

Journal: Cell host & microbe

Published: April 01, 2023

Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.

Durability of Adalimumab and Infliximab in Children With Crohn's Disease: A Nationwide Comparison From the epi-IIRN Cohort.

Journal: Inflammatory bowel diseases

Published: March 03, 2023

A personalized network framework reveals predictive axis of anti-TNF response across diseases.

A personalized network framework reveals predictive axis of anti-TNF response across diseases.

Journal: Cell reports. Medicine

Published: February 21, 2023

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience.

Journal: Vaccines

Published: January 27, 2022

Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

Journal: Journal of Crohn's & colitis

Published: December 01, 2021

Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.

Improved Outcomes of Paediatric and Adult Crohn's Disease and Association With Emerging Use of Biologics-A Nationwide Study From the Epi-IIRN.

Journal: Journal of Crohn's & colitis

Published: November 18, 2021

Showing 1-12 of 101

Last Updated: 09/26/2026